Artificial Pancreas Device System Market Size, Share, Growth and Trend Analysis Report, 2018 to 2024

22/ago/2019 11:57:15 susan hill Contatta l'autore

The global  artificial pancreas device system  is anticipated to reach USD 390.4 million by 2024, according to a new report by Grand View Research, Inc. Increasing prevalence of diabetes, intensive R&D efforts by industry players . 

Regulatory bodies such as FDA are continuously approved. For instance, in December 2016, OneTouch Vibe plus Insulin Pump by Animas received FDA approval and Health Canada License for the sale of the product. In January 2016, Animas received FDA approval for Animas Vibe Insulin Pump, the device to manage diabetes in children and adolescents.

Similarly, in June 2016, the FDA approved Tandem Diabetes Care approval for remote software update tool for insulin pump. Also, in September 2016, the company received FDA approval for their product: slim G4 Insulin

In addition, the prevalence of diabetes is increasing in low and middle-income counties. Owing to the sedentary lifestyle, genetic modification, obesity, lack of physical activity, and unhealthy diet. According to the data published by the International Diabetes Federation (IDF), in 2015 there were about 415 million people suffering from diabetes globally. Also, based on the information provided by the American Diabetes Association, in 2012, about 29.1 million Americans suffered from type 1 and 1.25 million suffered from type 1 diabetes. In addition, the increasing dependency of type 2

Further Key Findings from the Study Suggest :

  • Control to Target (CTT) systems is anticipated to witness faster growth during the forecast period.
  • Asia Pacific artificial pancreas device
  • Major players in the market include, Medtronic Plc, Bigfoot Biomedical, Johnson & Johnson, Tandem Diabetes Care, Inc., Pancreum, Inc., TypeZero Technologies, LLC, and Beta Bionics.

Grand View Research has segmented the global artificial pancreas device system on the basis of the device type and region:

Artificial Pancreas Device System Device Type Outlook (Revenue, USD Million, 2013 - 2024)

  • Threshold suspended device system
  • CTR System
  • CTT System

Artificial Pancreas Device System Regional Outlook (Revenue, USD Million, 2013 - 2024)

  • North America
    • US
    • Canada
  • europe
    • germany
    • UK
  • Asia Pacific
    • japan
    • china
  • Latin America
    • brazil
    • mexico
  • Middle East and Africa (MEA)
    • South Africa

Access full research on global artificial pancreas device system market:

blog comments powered by Disqus รจ un servizio offerto da Factotum Srl